Vanguard Group Inc Harvard Bioscience Inc Transaction History
Vanguard Group Inc
- $5.97 Trillion
- Q2 2025
A detailed history of Vanguard Group Inc transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Vanguard Group Inc holds 1,853,891 shares of HBIO stock, worth $889,867. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,853,891
Previous 2,138,749
13.32%
Holding current value
$889,867
Previous $1.22 Million
33.14%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding HBIO
# of Institutions
74Shares Held
22.5MCall Options Held
79.8KPut Options Held
11.5K-
Amh Equity LTD3.51MShares$1.68 Million2.13% of portfolio
-
Black Rock Inc. New York, NY2.84MShares$1.36 Million0.0% of portfolio
-
Harvey Partners, LLC Tarrytown, NY2.14MShares$1.03 Million0.1% of portfolio
-
Granahan Investment Management, LLC Waltham, MA1.5MShares$720,7230.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.13MShares$540,6000.0% of portfolio
About HARVARD BIOSCIENCE INC
- Ticker HBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 41,636,500
- Market Cap $20M
- Description
- Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...